Elevated serum levels of G-CSF, IL-6, and sICAM1 have been positively correlated with increased serum levels of Gal-3 in patients with metastatic colorectal cancer, suggesting a potential role of Gal-3 in tumor progression and metastatic dissemination [9]. Here, LGALS3 is linked to neoplasm.